nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—ABCB1—ovarian cancer	0.455	1	CbGaD
Flurazepam—ABCB1—Topotecan—ovarian cancer	0.0426	0.221	CbGbCtD
Flurazepam—ABCB1—Vinorelbine—ovarian cancer	0.03	0.156	CbGbCtD
Flurazepam—CYP3A4—Topotecan—ovarian cancer	0.0255	0.133	CbGbCtD
Flurazepam—ABCB1—Paclitaxel—ovarian cancer	0.0211	0.11	CbGbCtD
Flurazepam—CYP3A4—Vinorelbine—ovarian cancer	0.018	0.0935	CbGbCtD
Flurazepam—ABCB1—Docetaxel—ovarian cancer	0.0153	0.0793	CbGbCtD
Flurazepam—CYP3A4—Paclitaxel—ovarian cancer	0.0126	0.0657	CbGbCtD
Flurazepam—ABCB1—Doxorubicin—ovarian cancer	0.0114	0.0591	CbGbCtD
Flurazepam—CYP3A4—Docetaxel—ovarian cancer	0.00914	0.0475	CbGbCtD
Flurazepam—Lucanthone—TOP1—ovarian cancer	0.00895	0.626	CrCbGaD
Flurazepam—CYP3A4—Doxorubicin—ovarian cancer	0.00681	0.0354	CbGbCtD
Flurazepam—Amodiaquine—CYP1B1—ovarian cancer	0.00282	0.197	CrCbGaD
Flurazepam—GABRP—uterine cervix—ovarian cancer	0.00146	0.0439	CbGeAlD
Flurazepam—GABRE—myometrium—ovarian cancer	0.00143	0.0431	CbGeAlD
Flurazepam—GABRP—decidua—ovarian cancer	0.00139	0.0418	CbGeAlD
Flurazepam—Confusional state—Chlorambucil—ovarian cancer	0.00135	0.00511	CcSEcCtD
Flurazepam—Flushing—Vinorelbine—ovarian cancer	0.00133	0.00504	CcSEcCtD
Flurazepam—GABRP—endometrium—ovarian cancer	0.00132	0.0397	CbGeAlD
Flurazepam—Ataxia—Paclitaxel—ovarian cancer	0.00131	0.00496	CcSEcCtD
Flurazepam—Leukopenia—Topotecan—ovarian cancer	0.00131	0.00494	CcSEcCtD
Flurazepam—Leukopenia—Melphalan—ovarian cancer	0.00128	0.00484	CcSEcCtD
Flurazepam—Anorexia—Chlorambucil—ovarian cancer	0.00128	0.00483	CcSEcCtD
Flurazepam—GABRG3—testis—ovarian cancer	0.00127	0.0384	CbGeAlD
Flurazepam—Aspartate aminotransferase increased—Paclitaxel—ovarian cancer	0.00126	0.00475	CcSEcCtD
Flurazepam—Chest pain—Topotecan—ovarian cancer	0.00124	0.0047	CcSEcCtD
Flurazepam—Arthralgia—Topotecan—ovarian cancer	0.00124	0.0047	CcSEcCtD
Flurazepam—Chest pain—Melphalan—ovarian cancer	0.00122	0.0046	CcSEcCtD
Flurazepam—GABRP—uterus—ovarian cancer	0.00121	0.0366	CbGeAlD
Flurazepam—GABRR1—testis—ovarian cancer	0.00121	0.0365	CbGeAlD
Flurazepam—Lethargy—Docetaxel—ovarian cancer	0.00121	0.00456	CcSEcCtD
Flurazepam—Thinking abnormal—Epirubicin—ovarian cancer	0.0012	0.00454	CcSEcCtD
Flurazepam—Anaphylactic shock—Topotecan—ovarian cancer	0.00119	0.00451	CcSEcCtD
Flurazepam—Dyspepsia—Chlorambucil—ovarian cancer	0.00118	0.00446	CcSEcCtD
Flurazepam—Anaphylactic shock—Melphalan—ovarian cancer	0.00117	0.00441	CcSEcCtD
Flurazepam—Decreased appetite—Chlorambucil—ovarian cancer	0.00116	0.0044	CcSEcCtD
Flurazepam—Dysarthria—Epirubicin—ovarian cancer	0.00116	0.00439	CcSEcCtD
Flurazepam—Hyperhidrosis—Topotecan—ovarian cancer	0.00115	0.00436	CcSEcCtD
Flurazepam—Anorexia—Topotecan—ovarian cancer	0.00114	0.0043	CcSEcCtD
Flurazepam—Gait disturbance—Epirubicin—ovarian cancer	0.00113	0.00426	CcSEcCtD
Flurazepam—Leukopenia—Vinorelbine—ovarian cancer	0.00112	0.00423	CcSEcCtD
Flurazepam—Anorexia—Melphalan—ovarian cancer	0.00111	0.00421	CcSEcCtD
Flurazepam—Ataxia—Docetaxel—ovarian cancer	0.00111	0.00421	CcSEcCtD
Flurazepam—GABRE—uterine cervix—ovarian cancer	0.00111	0.0335	CbGeAlD
Flurazepam—Thinking abnormal—Doxorubicin—ovarian cancer	0.00111	0.0042	CcSEcCtD
Flurazepam—Palpitations—Vinorelbine—ovarian cancer	0.0011	0.00418	CcSEcCtD
Flurazepam—Feeling abnormal—Chlorambucil—ovarian cancer	0.0011	0.00417	CcSEcCtD
Flurazepam—GABRB1—vagina—ovarian cancer	0.0011	0.0332	CbGeAlD
Flurazepam—Phosphatase alkaline increased—Epirubicin—ovarian cancer	0.0011	0.00416	CcSEcCtD
Flurazepam—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00109	0.00414	CcSEcCtD
Flurazepam—GABRP—female reproductive system—ovarian cancer	0.00109	0.0329	CbGeAlD
Flurazepam—Hypotension—Melphalan—ovarian cancer	0.00109	0.00412	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00109	0.00411	CcSEcCtD
Flurazepam—Dysarthria—Doxorubicin—ovarian cancer	0.00107	0.00407	CcSEcCtD
Flurazepam—Salivary hypersecretion—Epirubicin—ovarian cancer	0.00107	0.00404	CcSEcCtD
Flurazepam—Aspartate aminotransferase increased—Docetaxel—ovarian cancer	0.00106	0.00403	CcSEcCtD
Flurazepam—Arthralgia—Vinorelbine—ovarian cancer	0.00106	0.00402	CcSEcCtD
Flurazepam—Chest pain—Vinorelbine—ovarian cancer	0.00106	0.00402	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00106	0.00402	CcSEcCtD
Flurazepam—Dyspnoea—Topotecan—ovarian cancer	0.00106	0.00402	CcSEcCtD
Flurazepam—GABRE—decidua—ovarian cancer	0.00106	0.0319	CbGeAlD
Flurazepam—GABRD—testis—ovarian cancer	0.00105	0.0318	CbGeAlD
Flurazepam—Dyspepsia—Topotecan—ovarian cancer	0.00105	0.00397	CcSEcCtD
Flurazepam—Gait disturbance—Doxorubicin—ovarian cancer	0.00104	0.00394	CcSEcCtD
Flurazepam—Dyspnoea—Melphalan—ovarian cancer	0.00104	0.00394	CcSEcCtD
Flurazepam—Decreased appetite—Topotecan—ovarian cancer	0.00104	0.00392	CcSEcCtD
Flurazepam—Dyspepsia—Melphalan—ovarian cancer	0.00103	0.00389	CcSEcCtD
Flurazepam—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00102	0.00386	CcSEcCtD
Flurazepam—Constipation—Topotecan—ovarian cancer	0.00102	0.00385	CcSEcCtD
Flurazepam—Phosphatase alkaline increased—Doxorubicin—ovarian cancer	0.00102	0.00385	CcSEcCtD
Flurazepam—Decreased appetite—Melphalan—ovarian cancer	0.00101	0.00384	CcSEcCtD
Flurazepam—GABRE—endometrium—ovarian cancer	0.00101	0.0303	CbGeAlD
Flurazepam—Coma—Epirubicin—ovarian cancer	0.001	0.0038	CcSEcCtD
Flurazepam—Salivary hypersecretion—Doxorubicin—ovarian cancer	0.000987	0.00373	CcSEcCtD
Flurazepam—GABRP—vagina—ovarian cancer	0.000987	0.0298	CbGeAlD
Flurazepam—Feeling abnormal—Topotecan—ovarian cancer	0.000982	0.00371	CcSEcCtD
Flurazepam—GABRA5—testis—ovarian cancer	0.000978	0.0295	CbGeAlD
Flurazepam—Gastrointestinal pain—Topotecan—ovarian cancer	0.000975	0.00369	CcSEcCtD
Flurazepam—Anorexia—Vinorelbine—ovarian cancer	0.000972	0.00368	CcSEcCtD
Flurazepam—Asthenia—Chlorambucil—ovarian cancer	0.000961	0.00363	CcSEcCtD
Flurazepam—Mental disability—Epirubicin—ovarian cancer	0.000954	0.00361	CcSEcCtD
Flurazepam—Hypotension—Vinorelbine—ovarian cancer	0.000953	0.0036	CcSEcCtD
Flurazepam—Pruritus—Chlorambucil—ovarian cancer	0.000947	0.00358	CcSEcCtD
Flurazepam—Coma—Doxorubicin—ovarian cancer	0.000929	0.00351	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000929	0.00351	CcSEcCtD
Flurazepam—Blood alkaline phosphatase increased—Epirubicin—ovarian cancer	0.000917	0.00347	CcSEcCtD
Flurazepam—Diarrhoea—Chlorambucil—ovarian cancer	0.000916	0.00346	CcSEcCtD
Flurazepam—GABRR2—lymph node—ovarian cancer	0.000913	0.0275	CbGeAlD
Flurazepam—GABRA3—testis—ovarian cancer	0.00091	0.0274	CbGeAlD
Flurazepam—Dyspnoea—Vinorelbine—ovarian cancer	0.000909	0.00344	CcSEcCtD
Flurazepam—Flushing—Paclitaxel—ovarian cancer	0.000896	0.00339	CcSEcCtD
Flurazepam—Decreased appetite—Vinorelbine—ovarian cancer	0.000886	0.00335	CcSEcCtD
Flurazepam—Mental disability—Doxorubicin—ovarian cancer	0.000882	0.00334	CcSEcCtD
Flurazepam—Constipation—Vinorelbine—ovarian cancer	0.000872	0.0033	CcSEcCtD
Flurazepam—CYP2A6—vagina—ovarian cancer	0.00086	0.0259	CbGeAlD
Flurazepam—Asthenia—Topotecan—ovarian cancer	0.000855	0.00323	CcSEcCtD
Flurazepam—Vomiting—Chlorambucil—ovarian cancer	0.000851	0.00322	CcSEcCtD
Flurazepam—Agranulocytosis—Docetaxel—ovarian cancer	0.00085	0.00322	CcSEcCtD
Flurazepam—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	0.000849	0.00321	CcSEcCtD
Flurazepam—Pruritus—Topotecan—ovarian cancer	0.000843	0.00319	CcSEcCtD
Flurazepam—Feeling abnormal—Vinorelbine—ovarian cancer	0.00084	0.00318	CcSEcCtD
Flurazepam—Asthenia—Melphalan—ovarian cancer	0.000837	0.00317	CcSEcCtD
Flurazepam—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000834	0.00315	CcSEcCtD
Flurazepam—GABRE—female reproductive system—ovarian cancer	0.000833	0.0251	CbGeAlD
Flurazepam—Pruritus—Melphalan—ovarian cancer	0.000826	0.00312	CcSEcCtD
Flurazepam—Tension—Paclitaxel—ovarian cancer	0.000825	0.00312	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.000824	0.00312	CcSEcCtD
Flurazepam—Dysgeusia—Paclitaxel—ovarian cancer	0.000823	0.00311	CcSEcCtD
Flurazepam—Nervousness—Paclitaxel—ovarian cancer	0.000816	0.00309	CcSEcCtD
Flurazepam—Diarrhoea—Topotecan—ovarian cancer	0.000815	0.00308	CcSEcCtD
Flurazepam—Lethargy—Epirubicin—ovarian cancer	0.000814	0.00308	CcSEcCtD
Flurazepam—Diarrhoea—Melphalan—ovarian cancer	0.000798	0.00302	CcSEcCtD
Flurazepam—Nausea—Chlorambucil—ovarian cancer	0.000795	0.00301	CcSEcCtD
Flurazepam—Vision blurred—Paclitaxel—ovarian cancer	0.000792	0.003	CcSEcCtD
Flurazepam—GABRB3—gonad—ovarian cancer	0.000791	0.0238	CbGeAlD
Flurazepam—Dizziness—Topotecan—ovarian cancer	0.000788	0.00298	CcSEcCtD
Flurazepam—Agitation—Paclitaxel—ovarian cancer	0.000772	0.00292	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000763	0.00288	CcSEcCtD
Flurazepam—GABRA2—vagina—ovarian cancer	0.00076	0.0229	CbGeAlD
Flurazepam—Flushing—Docetaxel—ovarian cancer	0.000759	0.00287	CcSEcCtD
Flurazepam—GABRE—female gonad—ovarian cancer	0.000758	0.0229	CbGeAlD
Flurazepam—Vomiting—Topotecan—ovarian cancer	0.000758	0.00287	CcSEcCtD
Flurazepam—Syncope—Paclitaxel—ovarian cancer	0.000754	0.00285	CcSEcCtD
Flurazepam—GABRE—vagina—ovarian cancer	0.000753	0.0227	CbGeAlD
Flurazepam—Lethargy—Doxorubicin—ovarian cancer	0.000753	0.00285	CcSEcCtD
Flurazepam—Leukopenia—Paclitaxel—ovarian cancer	0.000752	0.00284	CcSEcCtD
Flurazepam—Rash—Topotecan—ovarian cancer	0.000751	0.00284	CcSEcCtD
Flurazepam—Dermatitis—Topotecan—ovarian cancer	0.000751	0.00284	CcSEcCtD
Flurazepam—Ataxia—Epirubicin—ovarian cancer	0.00075	0.00284	CcSEcCtD
Flurazepam—Headache—Topotecan—ovarian cancer	0.000747	0.00282	CcSEcCtD
Flurazepam—Palpitations—Paclitaxel—ovarian cancer	0.000743	0.00281	CcSEcCtD
Flurazepam—GABRB2—testis—ovarian cancer	0.000742	0.0224	CbGeAlD
Flurazepam—Vomiting—Melphalan—ovarian cancer	0.000742	0.00281	CcSEcCtD
Flurazepam—Loss of consciousness—Paclitaxel—ovarian cancer	0.000739	0.00279	CcSEcCtD
Flurazepam—Rash—Melphalan—ovarian cancer	0.000736	0.00278	CcSEcCtD
Flurazepam—Dermatitis—Melphalan—ovarian cancer	0.000735	0.00278	CcSEcCtD
Flurazepam—Asthenia—Vinorelbine—ovarian cancer	0.000731	0.00277	CcSEcCtD
Flurazepam—Pruritus—Vinorelbine—ovarian cancer	0.000721	0.00273	CcSEcCtD
Flurazepam—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000718	0.00272	CcSEcCtD
Flurazepam—Chest pain—Paclitaxel—ovarian cancer	0.000715	0.00271	CcSEcCtD
Flurazepam—Arthralgia—Paclitaxel—ovarian cancer	0.000715	0.00271	CcSEcCtD
Flurazepam—Anxiety—Paclitaxel—ovarian cancer	0.000713	0.0027	CcSEcCtD
Flurazepam—Nausea—Topotecan—ovarian cancer	0.000708	0.00268	CcSEcCtD
Flurazepam—GABRB3—female reproductive system—ovarian cancer	0.000706	0.0213	CbGeAlD
Flurazepam—Dry mouth—Paclitaxel—ovarian cancer	0.0007	0.00265	CcSEcCtD
Flurazepam—Diarrhoea—Vinorelbine—ovarian cancer	0.000698	0.00264	CcSEcCtD
Flurazepam—Dysgeusia—Docetaxel—ovarian cancer	0.000697	0.00264	CcSEcCtD
Flurazepam—Ataxia—Doxorubicin—ovarian cancer	0.000694	0.00262	CcSEcCtD
Flurazepam—Nausea—Melphalan—ovarian cancer	0.000693	0.00262	CcSEcCtD
Flurazepam—Confusional state—Paclitaxel—ovarian cancer	0.000691	0.00262	CcSEcCtD
Flurazepam—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000686	0.00259	CcSEcCtD
Flurazepam—Shock—Paclitaxel—ovarian cancer	0.000675	0.00255	CcSEcCtD
Flurazepam—Dizziness—Vinorelbine—ovarian cancer	0.000674	0.00255	CcSEcCtD
Flurazepam—GABRE—testis—ovarian cancer	0.000672	0.0203	CbGeAlD
Flurazepam—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000665	0.00251	CcSEcCtD
Flurazepam—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000663	0.00251	CcSEcCtD
Flurazepam—Quinacrine—ABCB1—ovarian cancer	0.000659	0.0461	CrCbGaD
Flurazepam—Anorexia—Paclitaxel—ovarian cancer	0.000654	0.00247	CcSEcCtD
Flurazepam—Vomiting—Vinorelbine—ovarian cancer	0.000648	0.00245	CcSEcCtD
Flurazepam—Rash—Vinorelbine—ovarian cancer	0.000643	0.00243	CcSEcCtD
Flurazepam—Dermatitis—Vinorelbine—ovarian cancer	0.000642	0.00243	CcSEcCtD
Flurazepam—Hypotension—Paclitaxel—ovarian cancer	0.000641	0.00242	CcSEcCtD
Flurazepam—Headache—Vinorelbine—ovarian cancer	0.000639	0.00242	CcSEcCtD
Flurazepam—Syncope—Docetaxel—ovarian cancer	0.000639	0.00242	CcSEcCtD
Flurazepam—Leukopenia—Docetaxel—ovarian cancer	0.000638	0.00241	CcSEcCtD
Flurazepam—Palpitations—Docetaxel—ovarian cancer	0.000629	0.00238	CcSEcCtD
Flurazepam—Loss of consciousness—Docetaxel—ovarian cancer	0.000626	0.00237	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000625	0.00236	CcSEcCtD
Flurazepam—Drowsiness—Epirubicin—ovarian cancer	0.000615	0.00232	CcSEcCtD
Flurazepam—Dyspnoea—Paclitaxel—ovarian cancer	0.000611	0.00231	CcSEcCtD
Flurazepam—Somnolence—Paclitaxel—ovarian cancer	0.00061	0.00231	CcSEcCtD
Flurazepam—Arthralgia—Docetaxel—ovarian cancer	0.000606	0.00229	CcSEcCtD
Flurazepam—Chest pain—Docetaxel—ovarian cancer	0.000606	0.00229	CcSEcCtD
Flurazepam—Nausea—Vinorelbine—ovarian cancer	0.000606	0.00229	CcSEcCtD
Flurazepam—Dyspepsia—Paclitaxel—ovarian cancer	0.000604	0.00228	CcSEcCtD
Flurazepam—Decreased appetite—Paclitaxel—ovarian cancer	0.000596	0.00225	CcSEcCtD
Flurazepam—Dry mouth—Docetaxel—ovarian cancer	0.000593	0.00224	CcSEcCtD
Flurazepam—Sweating—Epirubicin—ovarian cancer	0.000589	0.00223	CcSEcCtD
Flurazepam—Constipation—Paclitaxel—ovarian cancer	0.000586	0.00222	CcSEcCtD
Flurazepam—Confusional state—Docetaxel—ovarian cancer	0.000586	0.00222	CcSEcCtD
Flurazepam—Chloroquine—ABCB1—ovarian cancer	0.000585	0.0409	CrCbGaD
Flurazepam—Anaphylactic shock—Docetaxel—ovarian cancer	0.000581	0.0022	CcSEcCtD
Flurazepam—Agranulocytosis—Epirubicin—ovarian cancer	0.000574	0.00217	CcSEcCtD
Flurazepam—Shock—Docetaxel—ovarian cancer	0.000572	0.00216	CcSEcCtD
Flurazepam—GABRB3—testis—ovarian cancer	0.00057	0.0172	CbGeAlD
Flurazepam—Drowsiness—Doxorubicin—ovarian cancer	0.000569	0.00215	CcSEcCtD
Flurazepam—Feeling abnormal—Paclitaxel—ovarian cancer	0.000565	0.00214	CcSEcCtD
Flurazepam—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000561	0.00212	CcSEcCtD
Flurazepam—Anorexia—Docetaxel—ovarian cancer	0.000554	0.0021	CcSEcCtD
Flurazepam—Sweating—Doxorubicin—ovarian cancer	0.000545	0.00206	CcSEcCtD
Flurazepam—Hypotension—Docetaxel—ovarian cancer	0.000543	0.00205	CcSEcCtD
Flurazepam—Agranulocytosis—Doxorubicin—ovarian cancer	0.000531	0.00201	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00053	0.002	CcSEcCtD
Flurazepam—Dyspnoea—Docetaxel—ovarian cancer	0.000518	0.00196	CcSEcCtD
Flurazepam—Somnolence—Docetaxel—ovarian cancer	0.000517	0.00195	CcSEcCtD
Flurazepam—Flushing—Epirubicin—ovarian cancer	0.000512	0.00194	CcSEcCtD
Flurazepam—Dyspepsia—Docetaxel—ovarian cancer	0.000512	0.00194	CcSEcCtD
Flurazepam—Decreased appetite—Docetaxel—ovarian cancer	0.000505	0.00191	CcSEcCtD
Flurazepam—Constipation—Docetaxel—ovarian cancer	0.000497	0.00188	CcSEcCtD
Flurazepam—Asthenia—Paclitaxel—ovarian cancer	0.000492	0.00186	CcSEcCtD
Flurazepam—GABRA2—lymph node—ovarian cancer	0.000491	0.0148	CbGeAlD
Flurazepam—GABRE—lymph node—ovarian cancer	0.000487	0.0147	CbGeAlD
Flurazepam—Pruritus—Paclitaxel—ovarian cancer	0.000485	0.00184	CcSEcCtD
Flurazepam—Feeling abnormal—Docetaxel—ovarian cancer	0.000479	0.00181	CcSEcCtD
Flurazepam—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000475	0.0018	CcSEcCtD
Flurazepam—Flushing—Doxorubicin—ovarian cancer	0.000474	0.00179	CcSEcCtD
Flurazepam—Tension—Epirubicin—ovarian cancer	0.000471	0.00178	CcSEcCtD
Flurazepam—Dysgeusia—Epirubicin—ovarian cancer	0.00047	0.00178	CcSEcCtD
Flurazepam—Diarrhoea—Paclitaxel—ovarian cancer	0.000469	0.00177	CcSEcCtD
Flurazepam—Nervousness—Epirubicin—ovarian cancer	0.000467	0.00176	CcSEcCtD
Flurazepam—Dizziness—Paclitaxel—ovarian cancer	0.000453	0.00172	CcSEcCtD
Flurazepam—Vision blurred—Epirubicin—ovarian cancer	0.000453	0.00171	CcSEcCtD
Flurazepam—CYP2E1—female reproductive system—ovarian cancer	0.000449	0.0135	CbGeAlD
Flurazepam—Agitation—Epirubicin—ovarian cancer	0.000441	0.00167	CcSEcCtD
Flurazepam—ABCB1—myometrium—ovarian cancer	0.000439	0.0132	CbGeAlD
Flurazepam—Tension—Doxorubicin—ovarian cancer	0.000436	0.00165	CcSEcCtD
Flurazepam—Vomiting—Paclitaxel—ovarian cancer	0.000436	0.00165	CcSEcCtD
Flurazepam—Dysgeusia—Doxorubicin—ovarian cancer	0.000435	0.00165	CcSEcCtD
Flurazepam—Rash—Paclitaxel—ovarian cancer	0.000432	0.00164	CcSEcCtD
Flurazepam—Dermatitis—Paclitaxel—ovarian cancer	0.000432	0.00163	CcSEcCtD
Flurazepam—Nervousness—Doxorubicin—ovarian cancer	0.000432	0.00163	CcSEcCtD
Flurazepam—Syncope—Epirubicin—ovarian cancer	0.000431	0.00163	CcSEcCtD
Flurazepam—Leukopenia—Epirubicin—ovarian cancer	0.00043	0.00163	CcSEcCtD
Flurazepam—Headache—Paclitaxel—ovarian cancer	0.00043	0.00162	CcSEcCtD
Flurazepam—Palpitations—Epirubicin—ovarian cancer	0.000425	0.00161	CcSEcCtD
Flurazepam—Loss of consciousness—Epirubicin—ovarian cancer	0.000422	0.0016	CcSEcCtD
Flurazepam—ABCB1—embryo—ovarian cancer	0.000422	0.0127	CbGeAlD
Flurazepam—Vision blurred—Doxorubicin—ovarian cancer	0.000419	0.00158	CcSEcCtD
Flurazepam—Asthenia—Docetaxel—ovarian cancer	0.000417	0.00158	CcSEcCtD
Flurazepam—Pruritus—Docetaxel—ovarian cancer	0.000411	0.00156	CcSEcCtD
Flurazepam—Chest pain—Epirubicin—ovarian cancer	0.000409	0.00155	CcSEcCtD
Flurazepam—Arthralgia—Epirubicin—ovarian cancer	0.000409	0.00155	CcSEcCtD
Flurazepam—Agitation—Doxorubicin—ovarian cancer	0.000408	0.00154	CcSEcCtD
Flurazepam—Anxiety—Epirubicin—ovarian cancer	0.000408	0.00154	CcSEcCtD
Flurazepam—Nausea—Paclitaxel—ovarian cancer	0.000407	0.00154	CcSEcCtD
Flurazepam—Dry mouth—Epirubicin—ovarian cancer	0.0004	0.00151	CcSEcCtD
Flurazepam—Syncope—Doxorubicin—ovarian cancer	0.000399	0.00151	CcSEcCtD
Flurazepam—Leukopenia—Doxorubicin—ovarian cancer	0.000398	0.0015	CcSEcCtD
Flurazepam—Diarrhoea—Docetaxel—ovarian cancer	0.000398	0.0015	CcSEcCtD
Flurazepam—Confusional state—Epirubicin—ovarian cancer	0.000395	0.0015	CcSEcCtD
Flurazepam—Palpitations—Doxorubicin—ovarian cancer	0.000393	0.00149	CcSEcCtD
Flurazepam—Anaphylactic shock—Epirubicin—ovarian cancer	0.000392	0.00148	CcSEcCtD
Flurazepam—Loss of consciousness—Doxorubicin—ovarian cancer	0.000391	0.00148	CcSEcCtD
Flurazepam—Shock—Epirubicin—ovarian cancer	0.000386	0.00146	CcSEcCtD
Flurazepam—Dizziness—Docetaxel—ovarian cancer	0.000384	0.00145	CcSEcCtD
Flurazepam—Hyperhidrosis—Epirubicin—ovarian cancer	0.000379	0.00143	CcSEcCtD
Flurazepam—Arthralgia—Doxorubicin—ovarian cancer	0.000378	0.00143	CcSEcCtD
Flurazepam—Chest pain—Doxorubicin—ovarian cancer	0.000378	0.00143	CcSEcCtD
Flurazepam—Anxiety—Doxorubicin—ovarian cancer	0.000377	0.00143	CcSEcCtD
Flurazepam—Anorexia—Epirubicin—ovarian cancer	0.000374	0.00141	CcSEcCtD
Flurazepam—Dry mouth—Doxorubicin—ovarian cancer	0.00037	0.0014	CcSEcCtD
Flurazepam—Vomiting—Docetaxel—ovarian cancer	0.00037	0.0014	CcSEcCtD
Flurazepam—Rash—Docetaxel—ovarian cancer	0.000366	0.00139	CcSEcCtD
Flurazepam—Hypotension—Epirubicin—ovarian cancer	0.000366	0.00139	CcSEcCtD
Flurazepam—Dermatitis—Docetaxel—ovarian cancer	0.000366	0.00138	CcSEcCtD
Flurazepam—Confusional state—Doxorubicin—ovarian cancer	0.000366	0.00138	CcSEcCtD
Flurazepam—Headache—Docetaxel—ovarian cancer	0.000364	0.00138	CcSEcCtD
Flurazepam—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000363	0.00137	CcSEcCtD
Flurazepam—CYP2E1—testis—ovarian cancer	0.000363	0.0109	CbGeAlD
Flurazepam—CYP3A4—female reproductive system—ovarian cancer	0.000361	0.0109	CbGeAlD
Flurazepam—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000357	0.00135	CcSEcCtD
Flurazepam—Shock—Doxorubicin—ovarian cancer	0.000357	0.00135	CcSEcCtD
Flurazepam—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000351	0.00133	CcSEcCtD
Flurazepam—Dyspnoea—Epirubicin—ovarian cancer	0.00035	0.00132	CcSEcCtD
Flurazepam—Somnolence—Epirubicin—ovarian cancer	0.000349	0.00132	CcSEcCtD
Flurazepam—Anorexia—Doxorubicin—ovarian cancer	0.000346	0.00131	CcSEcCtD
Flurazepam—Nausea—Docetaxel—ovarian cancer	0.000345	0.00131	CcSEcCtD
Flurazepam—Dyspepsia—Epirubicin—ovarian cancer	0.000345	0.00131	CcSEcCtD
Flurazepam—ABCB1—epithelium—ovarian cancer	0.000344	0.0104	CbGeAlD
Flurazepam—ABCB1—uterine cervix—ovarian cancer	0.000342	0.0103	CbGeAlD
Flurazepam—Decreased appetite—Epirubicin—ovarian cancer	0.000341	0.00129	CcSEcCtD
Flurazepam—Hypotension—Doxorubicin—ovarian cancer	0.000339	0.00128	CcSEcCtD
Flurazepam—Constipation—Epirubicin—ovarian cancer	0.000335	0.00127	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000331	0.00125	CcSEcCtD
Flurazepam—ABCB1—decidua—ovarian cancer	0.000325	0.00981	CbGeAlD
Flurazepam—Dyspnoea—Doxorubicin—ovarian cancer	0.000323	0.00122	CcSEcCtD
Flurazepam—Feeling abnormal—Epirubicin—ovarian cancer	0.000323	0.00122	CcSEcCtD
Flurazepam—Somnolence—Doxorubicin—ovarian cancer	0.000322	0.00122	CcSEcCtD
Flurazepam—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000321	0.00121	CcSEcCtD
Flurazepam—Dyspepsia—Doxorubicin—ovarian cancer	0.000319	0.00121	CcSEcCtD
Flurazepam—Decreased appetite—Doxorubicin—ovarian cancer	0.000315	0.00119	CcSEcCtD
Flurazepam—Constipation—Doxorubicin—ovarian cancer	0.00031	0.00117	CcSEcCtD
Flurazepam—ABCB1—endometrium—ovarian cancer	0.000309	0.00931	CbGeAlD
Flurazepam—Feeling abnormal—Doxorubicin—ovarian cancer	0.000299	0.00113	CcSEcCtD
Flurazepam—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000297	0.00112	CcSEcCtD
Flurazepam—Clobazam—ABCB1—ovarian cancer	0.000294	0.0206	CrCbGaD
Flurazepam—ABCB1—gonad—ovarian cancer	0.000287	0.00864	CbGeAlD
Flurazepam—ABCB1—uterus—ovarian cancer	0.000285	0.00858	CbGeAlD
Flurazepam—Asthenia—Epirubicin—ovarian cancer	0.000281	0.00106	CcSEcCtD
Flurazepam—Pruritus—Epirubicin—ovarian cancer	0.000277	0.00105	CcSEcCtD
Flurazepam—Diarrhoea—Epirubicin—ovarian cancer	0.000268	0.00101	CcSEcCtD
Flurazepam—Asthenia—Doxorubicin—ovarian cancer	0.00026	0.000984	CcSEcCtD
Flurazepam—Dizziness—Epirubicin—ovarian cancer	0.000259	0.000981	CcSEcCtD
Flurazepam—Pruritus—Doxorubicin—ovarian cancer	0.000257	0.000971	CcSEcCtD
Flurazepam—ABCB1—female reproductive system—ovarian cancer	0.000256	0.00772	CbGeAlD
Flurazepam—Vomiting—Epirubicin—ovarian cancer	0.000249	0.000943	CcSEcCtD
Flurazepam—Diarrhoea—Doxorubicin—ovarian cancer	0.000248	0.000939	CcSEcCtD
Flurazepam—Rash—Epirubicin—ovarian cancer	0.000247	0.000935	CcSEcCtD
Flurazepam—Dermatitis—Epirubicin—ovarian cancer	0.000247	0.000934	CcSEcCtD
Flurazepam—Headache—Epirubicin—ovarian cancer	0.000246	0.000929	CcSEcCtD
Flurazepam—ABCB1—bone marrow—ovarian cancer	0.000242	0.00728	CbGeAlD
Flurazepam—Dizziness—Doxorubicin—ovarian cancer	0.00024	0.000907	CcSEcCtD
Flurazepam—Nausea—Epirubicin—ovarian cancer	0.000233	0.000881	CcSEcCtD
Flurazepam—ABCB1—female gonad—ovarian cancer	0.000233	0.00702	CbGeAlD
Flurazepam—Clomipramine—ABCB1—ovarian cancer	0.000233	0.0163	CrCbGaD
Flurazepam—Chlorprothixene—ABCB1—ovarian cancer	0.000232	0.0162	CrCbGaD
Flurazepam—ABCB1—vagina—ovarian cancer	0.000231	0.00698	CbGeAlD
Flurazepam—Vomiting—Doxorubicin—ovarian cancer	0.000231	0.000872	CcSEcCtD
Flurazepam—Rash—Doxorubicin—ovarian cancer	0.000229	0.000865	CcSEcCtD
Flurazepam—Dermatitis—Doxorubicin—ovarian cancer	0.000229	0.000864	CcSEcCtD
Flurazepam—Headache—Doxorubicin—ovarian cancer	0.000227	0.00086	CcSEcCtD
Flurazepam—Nausea—Doxorubicin—ovarian cancer	0.000215	0.000815	CcSEcCtD
Flurazepam—ABCB1—testis—ovarian cancer	0.000206	0.00623	CbGeAlD
Flurazepam—Midazolam—ABCB1—ovarian cancer	0.000201	0.014	CrCbGaD
Flurazepam—Diazepam—ABCB1—ovarian cancer	0.000172	0.012	CrCbGaD
Flurazepam—Chlorpromazine—ABCB1—ovarian cancer	0.00016	0.0112	CrCbGaD
Flurazepam—ABCB1—lymph node—ovarian cancer	0.00015	0.00451	CbGeAlD
Flurazepam—GABRR1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	5.12e-05	0.00127	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.04e-05	0.00125	CbGpPWpGaD
Flurazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	4.98e-05	0.00123	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.97e-05	0.00123	CbGpPWpGaD
Flurazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	4.92e-05	0.00122	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—NME2—ovarian cancer	4.91e-05	0.00122	CbGpPWpGaD
Flurazepam—GABRR2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	4.88e-05	0.00121	CbGpPWpGaD
Flurazepam—GABRQ—Transmission across Chemical Synapses—MAPK1—ovarian cancer	4.88e-05	0.00121	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	4.84e-05	0.0012	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.71e-05	0.00117	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.58e-05	0.00113	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.55e-05	0.00113	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	4.51e-05	0.00112	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—STAT3—ovarian cancer	4.51e-05	0.00112	CbGpPWpGaD
Flurazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	4.5e-05	0.00111	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.49e-05	0.00111	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.42e-05	0.00109	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	4.42e-05	0.00109	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.42e-05	0.00109	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.39e-05	0.00109	CbGpPWpGaD
Flurazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	4.37e-05	0.00108	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.34e-05	0.00107	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	4.32e-05	0.00107	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.31e-05	0.00107	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—MAPK3—ovarian cancer	4.31e-05	0.00107	CbGpPWpGaD
Flurazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	4.29e-05	0.00106	CbGpPWpGaD
Flurazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	4.29e-05	0.00106	CbGpPWpGaD
Flurazepam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	4.27e-05	0.00106	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.27e-05	0.00106	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.26e-05	0.00106	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.24e-05	0.00105	CbGpPWpGaD
Flurazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	4.23e-05	0.00105	CbGpPWpGaD
Flurazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	4.22e-05	0.00105	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.2e-05	0.00104	CbGpPWpGaD
Flurazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	4.19e-05	0.00104	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	4.16e-05	0.00103	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.16e-05	0.00103	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	4.14e-05	0.00103	CbGpPWpGaD
Flurazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	4.12e-05	0.00102	CbGpPWpGaD
Flurazepam—GABRR1—Transmission across Chemical Synapses—HRAS—ovarian cancer	4.11e-05	0.00102	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—MAPK1—ovarian cancer	4.1e-05	0.00102	CbGpPWpGaD
Flurazepam—GABRG3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	4.02e-05	0.000996	CbGpPWpGaD
Flurazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	4e-05	0.000991	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.98e-05	0.000985	CbGpPWpGaD
Flurazepam—GABRB1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.96e-05	0.000981	CbGpPWpGaD
Flurazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.95e-05	0.000978	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.93e-05	0.000973	CbGpPWpGaD
Flurazepam—GABRR1—Neuronal System—MAPK1—ovarian cancer	3.92e-05	0.000971	CbGpPWpGaD
Flurazepam—GABRR2—Transmission across Chemical Synapses—HRAS—ovarian cancer	3.92e-05	0.000971	CbGpPWpGaD
Flurazepam—GABRQ—Transmission across Chemical Synapses—HRAS—ovarian cancer	3.92e-05	0.000971	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	3.9e-05	0.000966	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—NME2—ovarian cancer	3.88e-05	0.000961	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.77e-05	0.000933	CbGpPWpGaD
Flurazepam—GABRA6—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.75e-05	0.000928	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	3.74e-05	0.000928	CbGpPWpGaD
Flurazepam—GABRQ—Neuronal System—MAPK1—ovarian cancer	3.74e-05	0.000926	CbGpPWpGaD
Flurazepam—GABRR2—Neuronal System—MAPK1—ovarian cancer	3.74e-05	0.000926	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	3.73e-05	0.000925	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CASP3—ovarian cancer	3.73e-05	0.000925	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL2—ovarian cancer	3.73e-05	0.000923	CbGpPWpGaD
Flurazepam—GABRA4—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.7e-05	0.000916	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	3.67e-05	0.000908	CbGpPWpGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	3.66e-05	0.000906	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.64e-05	0.000901	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	3.63e-05	0.000898	CbGpPWpGaD
Flurazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.61e-05	0.000895	CbGpPWpGaD
Flurazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	3.6e-05	0.000891	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.59e-05	0.00089	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	3.58e-05	0.000887	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	3.56e-05	0.000882	CbGpPWpGaD
Flurazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.51e-05	0.000869	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.49e-05	0.000864	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.46e-05	0.000856	CbGpPWpGaD
Flurazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.45e-05	0.000854	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CYTB—ovarian cancer	3.44e-05	0.000853	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.43e-05	0.000849	CbGpPWpGaD
Flurazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.39e-05	0.000839	CbGpPWpGaD
Flurazepam—GABRB2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.38e-05	0.000838	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.37e-05	0.000834	CbGpPWpGaD
Flurazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.36e-05	0.000833	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.34e-05	0.000829	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.34e-05	0.000827	CbGpPWpGaD
Flurazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.3e-05	0.000818	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—HRAS—ovarian cancer	3.29e-05	0.000815	CbGpPWpGaD
Flurazepam—GABRA5—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.29e-05	0.000814	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.28e-05	0.000814	CbGpPWpGaD
Flurazepam—GABRA3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.23e-05	0.000799	CbGpPWpGaD
Flurazepam—GABRG3—Transmission across Chemical Synapses—HRAS—ovarian cancer	3.23e-05	0.000799	CbGpPWpGaD
Flurazepam—GABRB1—Transmission across Chemical Synapses—HRAS—ovarian cancer	3.18e-05	0.000787	CbGpPWpGaD
Flurazepam—GABRA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.17e-05	0.000786	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	3.17e-05	0.000785	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CYTB—ovarian cancer	3.16e-05	0.000783	CbGpPWpGaD
Flurazepam—GABRB3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.15e-05	0.00078	CbGpPWpGaD
Flurazepam—GABRR1—Neuronal System—HRAS—ovarian cancer	3.15e-05	0.00078	CbGpPWpGaD
Flurazepam—GABRG2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.09e-05	0.000766	CbGpPWpGaD
Flurazepam—GABRG3—Neuronal System—MAPK1—ovarian cancer	3.08e-05	0.000763	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—MAPK1—ovarian cancer	3.03e-05	0.000751	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—BRIP1—ovarian cancer	3.01e-05	0.000746	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PPP1CC—ovarian cancer	3.01e-05	0.000746	CbGpPWpGaD
Flurazepam—GABRA6—Transmission across Chemical Synapses—HRAS—ovarian cancer	3.01e-05	0.000745	CbGpPWpGaD
Flurazepam—GABRR2—Neuronal System—HRAS—ovarian cancer	3e-05	0.000744	CbGpPWpGaD
Flurazepam—GABRQ—Neuronal System—HRAS—ovarian cancer	3e-05	0.000744	CbGpPWpGaD
Flurazepam—GABRA4—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.97e-05	0.000736	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	2.95e-05	0.000731	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—NME2—ovarian cancer	2.92e-05	0.000723	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	2.91e-05	0.000721	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—AKT1—ovarian cancer	2.9e-05	0.00072	CbGpPWpGaD
Flurazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	2.89e-05	0.000715	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.87e-05	0.000711	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—MAPK1—ovarian cancer	2.87e-05	0.000711	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—MAPK1—ovarian cancer	2.83e-05	0.000702	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.83e-05	0.000701	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	2.77e-05	0.000685	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PPP1CC—ovarian cancer	2.76e-05	0.000685	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—BRIP1—ovarian cancer	2.76e-05	0.000685	CbGpPWpGaD
Flurazepam—GABRB2—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.72e-05	0.000673	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.7e-05	0.00067	CbGpPWpGaD
Flurazepam—GABRA5—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.64e-05	0.000654	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.64e-05	0.000653	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2.61e-05	0.000648	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—MAPK1—ovarian cancer	2.59e-05	0.000642	CbGpPWpGaD
Flurazepam—GABRA3—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.59e-05	0.000642	CbGpPWpGaD
Flurazepam—GABRA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.55e-05	0.000631	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL6—ovarian cancer	2.53e-05	0.000628	CbGpPWpGaD
Flurazepam—GABRB3—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.53e-05	0.000627	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—MAPK1—ovarian cancer	2.52e-05	0.000624	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CYTB—ovarian cancer	2.5e-05	0.000619	CbGpPWpGaD
Flurazepam—GABRG2—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.48e-05	0.000615	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.48e-05	0.000615	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—MAPK1—ovarian cancer	2.47e-05	0.000612	CbGpPWpGaD
Flurazepam—GABRG3—Neuronal System—HRAS—ovarian cancer	2.47e-05	0.000612	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—HRAS—ovarian cancer	2.44e-05	0.000603	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—MAPK1—ovarian cancer	2.43e-05	0.000602	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—MAPK1—ovarian cancer	2.41e-05	0.000598	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—MAPK1—ovarian cancer	2.37e-05	0.000587	CbGpPWpGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	2.33e-05	0.000578	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—HRAS—ovarian cancer	2.3e-05	0.000571	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—HRAS—ovarian cancer	2.28e-05	0.000564	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PPP1CC—ovarian cancer	2.18e-05	0.000541	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—BRIP1—ovarian cancer	2.18e-05	0.000541	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.17e-05	0.000538	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—HRAS—ovarian cancer	2.08e-05	0.000515	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—MAPK1—ovarian cancer	2.07e-05	0.000513	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	2.03e-05	0.000503	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—HRAS—ovarian cancer	2.02e-05	0.000501	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—YAP1—ovarian cancer	2.02e-05	0.0005	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.99e-05	0.000494	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—HRAS—ovarian cancer	1.99e-05	0.000492	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—HRAS—ovarian cancer	1.95e-05	0.000483	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—HRAS—ovarian cancer	1.94e-05	0.00048	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—HRAS—ovarian cancer	1.9e-05	0.000471	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—MAPK1—ovarian cancer	1.9e-05	0.000471	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.89e-05	0.000468	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CYTB—ovarian cancer	1.88e-05	0.000466	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.88e-05	0.000466	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—YAP1—ovarian cancer	1.85e-05	0.000459	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.84e-05	0.000456	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.82e-05	0.000452	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—NME2—ovarian cancer	1.8e-05	0.000446	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.79e-05	0.000444	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.78e-05	0.00044	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.73e-05	0.000429	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—HRAS—ovarian cancer	1.66e-05	0.000412	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—FASN—ovarian cancer	1.65e-05	0.000408	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—BRIP1—ovarian cancer	1.64e-05	0.000407	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.64e-05	0.000407	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—SLC5A5—ovarian cancer	1.62e-05	0.000401	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—SLC2A1—ovarian cancer	1.56e-05	0.000387	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.56e-05	0.000387	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—HRAS—ovarian cancer	1.53e-05	0.000378	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—FASN—ovarian cancer	1.51e-05	0.000374	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CYP1B1—ovarian cancer	1.5e-05	0.000371	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—SLC5A5—ovarian cancer	1.49e-05	0.000368	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.48e-05	0.000366	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—YAP1—ovarian cancer	1.46e-05	0.000363	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.44e-05	0.000356	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—SLC2A1—ovarian cancer	1.44e-05	0.000356	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.41e-05	0.000349	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.41e-05	0.000349	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CYP1B1—ovarian cancer	1.38e-05	0.000341	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PPP2R1A—ovarian cancer	1.33e-05	0.000329	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.33e-05	0.000329	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ABCB1—ovarian cancer	1.23e-05	0.000306	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.22e-05	0.000302	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	1.22e-05	0.000302	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—TYMS—ovarian cancer	1.21e-05	0.0003	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—FASN—ovarian cancer	1.19e-05	0.000296	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.18e-05	0.000293	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—SLC5A5—ovarian cancer	1.17e-05	0.000291	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CYTB—ovarian cancer	1.16e-05	0.000287	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—SLC2A1—ovarian cancer	1.13e-05	0.000281	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ABCB1—ovarian cancer	1.13e-05	0.000281	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—TYMS—ovarian cancer	1.11e-05	0.000276	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—YAP1—ovarian cancer	1.1e-05	0.000273	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CYP1B1—ovarian cancer	1.09e-05	0.000269	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.01e-05	0.000251	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.01e-05	0.000251	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	9.98e-06	0.000247	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CAV1—ovarian cancer	9.77e-06	0.000242	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	9.65e-06	0.000239	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—FASN—ovarian cancer	8.99e-06	0.000223	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CAV1—ovarian cancer	8.97e-06	0.000222	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ABCB1—ovarian cancer	8.96e-06	0.000222	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PIK3CG—ovarian cancer	8.9e-06	0.00022	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—SLC5A5—ovarian cancer	8.85e-06	0.000219	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—TYMS—ovarian cancer	8.8e-06	0.000218	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—SLC2A1—ovarian cancer	8.54e-06	0.000212	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CYP1B1—ovarian cancer	8.19e-06	0.000203	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PIK3CG—ovarian cancer	8.17e-06	0.000202	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PIK3CD—ovarian cancer	7.82e-06	0.000194	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PPP2R1A—ovarian cancer	7.26e-06	0.00018	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PIK3CD—ovarian cancer	7.18e-06	0.000178	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CAV1—ovarian cancer	7.09e-06	0.000176	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PIK3CB—ovarian cancer	6.82e-06	0.000169	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—YAP1—ovarian cancer	6.8e-06	0.000168	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—TYMS—ovarian cancer	6.62e-06	0.000164	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PIK3CG—ovarian cancer	6.46e-06	0.00016	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PIK3CB—ovarian cancer	6.26e-06	0.000155	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PTEN—ovarian cancer	5.89e-06	0.000146	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PIK3CD—ovarian cancer	5.68e-06	0.000141	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—FASN—ovarian cancer	5.54e-06	0.000137	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—SLC5A5—ovarian cancer	5.45e-06	0.000135	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PTEN—ovarian cancer	5.41e-06	0.000134	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CAV1—ovarian cancer	5.34e-06	0.000132	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—SLC2A1—ovarian cancer	5.26e-06	0.00013	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CYP1B1—ovarian cancer	5.05e-06	0.000125	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PIK3CB—ovarian cancer	4.95e-06	0.000123	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PIK3CG—ovarian cancer	4.86e-06	0.00012	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.48e-06	0.000111	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PTEN—ovarian cancer	4.27e-06	0.000106	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PIK3CD—ovarian cancer	4.27e-06	0.000106	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PIK3CA—ovarian cancer	4.16e-06	0.000103	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.16e-06	0.000103	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—TYMS—ovarian cancer	4.08e-06	0.000101	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PIK3CA—ovarian cancer	3.82e-06	9.45e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.73e-06	9.23e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—AKT1—ovarian cancer	3.4e-06	8.41e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CAV1—ovarian cancer	3.29e-06	8.15e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PTEN—ovarian cancer	3.22e-06	7.97e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—AKT1—ovarian cancer	3.12e-06	7.72e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PIK3CA—ovarian cancer	3.02e-06	7.47e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3e-06	7.42e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.63e-06	6.52e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—AKT1—ovarian cancer	2.46e-06	6.1e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.3e-06	5.69e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.27e-06	5.63e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PTEN—ovarian cancer	1.98e-06	4.91e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—AKT1—ovarian cancer	1.86e-06	4.6e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.4e-06	3.47e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—AKT1—ovarian cancer	1.14e-06	2.83e-05	CbGpPWpGaD
